New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative

A recent article published in the Orphanet Journal of Rare Diseases highlights the launch and goals of RARE-Impact, a new European project designed to enhance the diagnosis, care, and overall…

Continue Reading New European Project Aims to Improve Rare Disease Diagnosis and Care: Insights from the RARE-Impact Initiative
Gene Therapy Promising for Cerebral Adrenoleukodystrophy but Carries Risk of Blood Cancer
source: shutterstock.com

Gene Therapy Promising for Cerebral Adrenoleukodystrophy but Carries Risk of Blood Cancer

The use of the gene therapy elivaldogene autotemcel (Skysona), has been approved due to its success in the treatment of patients diagnosed with the neurological disease cerebral adrenoleukodystrophy (CALD). The…

Continue Reading Gene Therapy Promising for Cerebral Adrenoleukodystrophy but Carries Risk of Blood Cancer
Alzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory
Kapa65 / Pixabay

Alzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory

The Riken Center team, headed by Dr. Takaomi Saido and using mice with Alzheimer’s, discovered that dopamine may lessen the brain’s physical symptoms and improve memory. The study, featured in…

Continue Reading Alzheimer’s: Researchers at Japan’s Riken Center Discover a New Treatment to Alleviate Symptoms and Improve Memory
Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s
source: shutterstock.com

Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s

According to a story from Healio, analysis of the FDA Adverse Events Reporting System database indicates that tirzepatide has a superior safety profile when compared to GLP-1 inhibitors that have…

Continue Reading Study: Tirzepatide Lowers Risk of Pancreatitis and Diabetic Retinopathy vs GLP-1s
When Might You Consider Genetic Testing for Alzheimer’s Disease?
source: shutterstock.com

When Might You Consider Genetic Testing for Alzheimer’s Disease?

This article was written by and shared with permission from Shannon Wieloch, MS. Shannon is a certified genetic counselor and patient advocate for the Aicardi-Goutiere Syndrome Advocacy Association and founder of Stork Genetics.…

Continue Reading When Might You Consider Genetic Testing for Alzheimer’s Disease?